Spark-Tech Biobanking System (STBS) and its components pictured in red cross are to streamline diagnostic effort. Figure illustrates that specimen collection (green frame) can be done simply in various conditions. Later STBS in automated fashion separates and preserves patient samples which can be send to analyses remotely (blue frame).
SPARK-TECH presented innovative Spark-Tech Biobanking System (STBS) at 2018 BIO International Convention in Boston (US).
SPARK-TECH is a commercialization partner in Nationally funded project „Diagnostics of the biochemical alterations in packed human red blood cells (PRBCs) with the use of vibrational spectroscopy”. Project aims to develop spectroscopic methodology for the Raman (RS) and Infrared (IR) diagnostic quality assessment of the pre-transfusion RBCs. Project was awarded by NCBiR to Katarzyna Marzec Ph.D. within LIDER program. http://jcet.eu/new_en/research/#012
Today, we received information, that our company brand SPARK-TECH has been registered as the European Union trademark by the European Union Office Intellectual Property Office.
Today, we received information, that the Polish Patent Office registered the SPARK-TECH logo.
SPARK-TECH team is ready to present innovative Spark-Tech Biobanking System (STBS) at BIO CONVENTION 2017 in San Diego (US).
Visit us at EU PAVILLON – Booth #5837!
On September 14th, 2016, it has been signed the grant agreement between the European Commission and SPARK-TECH Ltd. The company received support for preparing business plan for the development of a new medical device.
On May 3rd, 2016, SPARK-TECH Ltd. re-submitted project proposal to the SME Instrument Program under frames of the European Union Program – HORIZON 2020.
On September 17th, 2015, SPARK-TECH Ltd. submitted project proposal to the SME Instrument Program under frames of the European Union Program – HORIZON 2020. The project aims to develop new medical device.